Lobucavir

Lobucavir

SCHEMBL7699733

Nc1nc2c(ncn2[C@H]2C[C@H](CO)[C@@H]2CO)c(=O)[nH]1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.53
ADORA3 P0DMS8 1/20 0.53
PNP P00491 4/20 0.52
TK1 P04183 2/20 0.49
AHCY P23526 2/20 0.48
BLM P54132 2/20 0.47
USP2 O75604 1/20 0.47
TSHR P16473 1/20 0.47
EDNRA P25101 1/20 0.47
HTR2A P28223 1/20 0.47
RECQL P46063 1/20 0.47
HBB P68871 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
VCP P55072 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lobucavir SCHEMBL598707 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL5990162 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL10460499 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL51919 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL418430 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL9615453 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL9615451 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL15630215 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL51918 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY
Lobucavir SCHEMBL7166488 1.00 HPRT1 (0.53) HPRT1ADORA3PNPTK1AHCY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6348586-B1 NUCLEOTIDE SEQUENCE OF HERPES VIRUS; DIAGNOSIS; VACCINES; VIRICIDES; ANTISENSE AGENTS; TRIPLEX OLIGONUCLEOTIDES; THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2002-02-19 US disclosed
EP-0358154-B1 Novel cyclobutane derivative and process for producing same NIPPON KAYAKU KK (JP) 1998-12-02 EP disclosed
US-5246931-A Triazine-substituted cyclobutane derivatives; viricides; side effect reduction BRISTOL-MYERS SQUIBB COMPANY (US) 1993-09-21 US disclosed
US-5198583-A Optically active cyclobutane nucleoside and intermediates, therefor E. R. SQUIBB & SONS, INC. (US) 1993-03-30 US disclosed
US-5153352-A Viricides and antitumor agent BRISTOL-MYERS SQUIBB COMPANY (US) 1992-10-06 US disclosed
US-5064961-A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDE E. R. SQUIBB & SONS, INC. (US) 1991-11-12 US disclosed
EP-0366059-A2 Carbocyclic nucleoside analogs BRISTOL-MYERS SQUIBB COMPANY (US) 1990-05-02 EP disclosed
EP-0358154-A2 Novel cyclobutane derivative and process for producing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1990-03-14 EP disclosed